Masimo Corporation (MASI)

NASDAQ: MASI · IEX Real-Time Price · USD
133.44
+0.76 (0.57%)
At close: Mar 18, 2024, 4:00 PM
132.86
-0.58 (-0.43%)
After-hours: Mar 18, 2024, 5:45 PM EDT
0.57%
Market Cap 7.02B
Revenue (ttm) 2.05B
Net Income (ttm) 81.50M
Shares Out 52.91M
EPS (ttm) 1.51
PE Ratio 88.37
Forward PE 38.41
Dividend n/a
Ex-Dividend Date n/a
Volume 330,427
Open 133.00
Previous Close 132.68
Day's Range 132.43 - 134.14
52-Week Range 75.22 - 198.00
Beta 0.95
Analysts Hold
Price Target 127.80 (-4.23%)
Earnings Date May 7, 2024

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional... [Read more]

Sector Healthcare
IPO Date Aug 8, 2007
Employees 3,800
Stock Exchange NASDAQ
Ticker Symbol MASI
Full Company Profile

Financial Performance

In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for MASI stock is "Hold." The 12-month stock price forecast is $127.8, which is a decrease of -4.23% from the latest price.

Price Target
$127.8
(-4.23% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Masimo to Present in 45th Annual Raymond James Institutional Investors Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 202...

14 days ago - Business Wire

Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 30, 2023. Fourth Quarter 2023 Results: Consolidated rev...

20 days ago - Business Wire

Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth

IRVINE, Calif. & DENVER--(BUSINESS WIRE)--Masimo and UCHealth are entering into a strategic collaboration to improve patient care using the latest in virtual care and telehealth capabilities.

27 days ago - Business Wire

New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion

IRVINE, Calif.--(BUSINESS WIRE)--A new study has found that Masimo RD SET® pulse oximetry sensors accurately measure SpO2 on both Black and White subjects even when perfusion is low.

5 weeks ago - Business Wire

Masimo CEO: Would Be Happy With Win-Win Apple Settlement

Apple will begin selling versions of its Series 9 and Ultra 2 watches without a blood oxygen feature in the US, following a legal setback in its patent dispute with Masimo. Masimo CEO Joseph Kiani joi...

2 months ago - Bloomberg Technology

Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches

IRVINE, Calif.--(BUSINESS WIRE)--The Federal Circuit has lifted the temporary stay on the import ban of certain Apple Watch models.

Other symbols: AAPL
2 months ago - Business Wire

Ex-Disney Chief Bob Chapek Appointed To Board Of Medical Firm Masimo As Company Battles Apple

Bob Chapek, a nearly three-decade Disney veteran who was ousted in 2022 as the media company's CEO, has been appointed to the board of directors of medical tech firm Masimo. The move comes during a dr...

2 months ago - Deadline

Masimo Announces New Member of the Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Bob Chapek has been appointed to Masimo's Board of Directors. Mr. Chapek was Chief Executive Officer of The Walt Disney Comp...

2 months ago - Business Wire

U.S. appeals court upholds tribunal decisions in Apple-Masimo patent dispute

A U.S. appeals court on Friday upheld two earlier decisions by a patent tribunal that favored Masimo in its intellectual property dispute with Apple over blood oxygen sensors in newer Apple Watch mode...

Other symbols: AAPL
2 months ago - Reuters

Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance

IRVINE, California--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 30, 2023 and provided es...

2 months ago - Business Wire

Can Apple and Masimo Settle Their Differences?

Nicholas Matich, an intellectual property lawyer and former acting general counsel of the United States Patent and Trademark Office, explains how he thinks Apple's patent dispute with Masimo will play...

Other symbols: AAPL
3 months ago - Bloomberg Technology

Masimo CEO Addresses Smartwatch Patent Dispute With Apple

Masimo CEO Joe Kiani says Apple should apologize for copying his company's patented technology for measuring blood-oxygen levels in Apple's smartwatches. A US import ban on certain Apple Watches is se...

Other symbols: AAPL
3 months ago - Bloomberg Technology

Masimo CEO on Apple patent dispute: We are the rightful creator and inventor of this technology

Joe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss Apple pausing some Watch sales due to a patent dispute.

Other symbols: AAPL
3 months ago - CNBC Television

Masimo Receives FDA Clearance for Stork™ Baby Monitoring System

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Stork™, a revolutionary baby monitoring system, has received FDA clearance for prescription use to continuously monitor babies at home.

3 months ago - Business Wire

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation

NEUCHATEL, Switzerland--(BUSINESS WIRE)--In the largest study of Masimo ORi™ to date, researchers found a significant correlation between ORi and PaO2 during one-lung ventilation.

3 months ago - Business Wire

Masimo to Present in Piper Sandler 35th Annual Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:...

4 months ago - Business Wire

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

IRVINE, Calif.--(BUSINESS WIRE)--The Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter and prescription use.

4 months ago - Business Wire

Masimo to Present in Jefferies London Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Wednesday, November 15, 2023 at 3:00 pm GMT...

4 months ago - Business Wire

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)--GE HealthCare and Masimo announced a joint agreement to integrate Masimo SET® into the GE HealthCare Portrait Mobile platform.

Other symbols: GEHC
4 months ago - Business Wire

Masimo Reports Third Quarter 2023 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter of 2023, ended September 30, 2023. Third Quarter 2023 Financial Results C...

4 months ago - Business Wire

United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws

WASHINGTON--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches ...

Other symbols: AAPL
5 months ago - Business Wire

Apple responds to Masimo patent dispute over smart watches

Apple puts out statement in response to a International Trade Commission ruling that claims it violated patent law concerning its smart watches.

Other symbols: AAPL
5 months ago - CNBC Television

Masimo to Report Third Quarter 2023 Financial Results after Market Close on Tuesday, November 7

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2023 financial results for the period ended September 30, 2023, after the market closes on Tuesday, November 7, 2023. ...

5 months ago - Business Wire

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Masimo Investors of a Lead Plaintiff Deadline of October 23, 2023

NEW YORK , Oct. 23, 2023 /PRNewswire/ -- Attention Masimo Corporation ("Masimo") (NASDAQ: MASI) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on beha...

5 months ago - PRNewsWire

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Masimo Corporation with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 23, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Masimo Corporation ("Masimo" o...

5 months ago - Accesswire